Sugi Predict

Sugi Predict / Compounds / SCHEMBL5339288

SCHEMBL5339288

SCHEMBL5339288

CN1C(=O)C(C2=COc3ccccc3O2)=C(c2cn(C(=O)O)c3ccc(OCc4ccccc4)cc23)C1=O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.38
▸ SRD5A2 P31213 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ SENP8 Q96LD8 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ AS3MT Q9HBK9 1/20 0.36
▸ EDNRB P24530 4/20 0.36
▸ EDNRA P25101 4/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ LTB4R Q15722 1/20 0.35
▸ LTB4R2 Q9NPC1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5341756 0.93 SIRT2 (0.38) MAOBSRD5A2NPC1RAB9ACASP3
SCHEMBL5337035 0.88 GHSR (0.34) MAOBSRD5A2CASP3SENP8SENP7
SCHEMBL5333904 0.83 SIRT2 (0.44) SIRT2
SCHEMBL5347008 0.82 GHSR (0.33) MAOBCASP3SENP8SENP7SENP6
SCHEMBL5334606 0.81 MAOB (0.44) MAOBSRD5A2MEN1NPC1RAB9A
SCHEMBL5337356 0.80 SIRT2 (0.42) SIRT2
Tert-Butyl Formate SCHEMBL28771408 0.75 ACHE (0.39) MAOBMEN1KMT2ASIRT2MAOA
SCHEMBL5337989 0.74 SRD5A2 (0.41) MAOBSRD5A2MEN1NPC1RAB9A
SCHEMBL5341440 0.70 CCNT1 (0.53) SIRT2
SCHEMBL5344531 0.69 GHSR (0.38) MAOBSRD5A2MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202255-B2 Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2007-04-10 — — US disclosed
EP-1587810-B1 NOVEL SUBSTITUTED 1,4|BENZODIOXINO 2,3-E|ISOINDOLE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2006-11-08 — — EP disclosed
US-20060040930-A1 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2006-02-23 — — US disclosed
EP-1587810-A1 NOVEL SUBSTITUTED 1,4]BENZODIOXINO 2,3-E]ISOINDOLE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2005-10-26 — — EP disclosed
WO-2004037831-A1 NOVEL SUBSTITUTED[1,4]BENZODIOXINO[2,3-E]ISOINDOLE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2004-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040930-A1 Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same CYP11B2, CYP2F1, CYP3A43 MAOB 71/4885SRD5A2 186/4885MEN1 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.